{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:56:04Z","timestamp":1791687364727,"version":"4.3.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Science and Health Joint Medical Research Project of Chongqing","award":["2024ZDXM004"],"award-info":[{"award-number":["2024ZDXM004"]}]},{"name":"Senior Medical Talents program of Chongqing for Young and Middle aged"},{"name":"Kuanren Talents Program of the second affiliated hospital of Chongqing Medical University"},{"name":"Program for Youth Innovation in Future Medicine, Chongqing Medical University","award":["W0140"],"award-info":[{"award-number":["W0140"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"DOI":"10.1186\/s12894-025-01884-7","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T04:49:41Z","timestamp":1754887781000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A novel composite index of PSA and periprostatic adipose tissue quantification for enhancing high-grade prostate cancer prediction"],"prefix":"10.1186","volume":"25","author":[{"given":"Jie","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyong","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangqin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,11]]},"reference":[{"issue":"8","key":"1884_CR1","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nrendo.2014.94","volume":"10","author":"J Park","year":"2014","unstructured":"Park J, Morley T, Kim M, Clegg D, Scherer P. Obesity and cancer\u2013mechanisms underlying tumour progression and recurrence. Nat Rev Endocrinol. 2014;10(8):455\u201365. https:\/\/doi.org\/10.1038\/nrendo.2014.94.","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"1884_CR2","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/pcan.2015.64","volume":"19","author":"S Zhong","year":"2016","unstructured":"Zhong S, Yan X, Wu Y, et al. Body mass index and mortality in prostate cancer patients: a dose-response meta-analysis. Prostate Cancer Prostatic Dis. 2016;19(2):122\u201331. https:\/\/doi.org\/10.1038\/pcan.2015.64.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"6","key":"1884_CR3","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1210\/edrv.21.6.0415","volume":"21","author":"B Wajchenberg","year":"2000","unstructured":"Wajchenberg B. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev. 2000;21(6):697\u2013738. https:\/\/doi.org\/10.1210\/edrv.21.6.0415.","journal-title":"Endocr Rev"},{"key":"1884_CR4","doi-asserted-by":"publisher","first-page":"10230","DOI":"10.1038\/ncomms10230","volume":"7","author":"V Laurent","year":"2016","unstructured":"Laurent V, Gu\u00e9rard A, Mazerolles C, et al. Periprostatic adipocytes act as a driving force for prostate cancer progression in obesity. Nat Commun. 2016;7:10230. https:\/\/doi.org\/10.1038\/ncomms10230.","journal-title":"Nat Commun"},{"issue":"1","key":"1884_CR5","doi-asserted-by":"publisher","first-page":"4630","DOI":"10.1038\/s41598-017-04951-8","volume":"7","author":"N Dahran","year":"2017","unstructured":"Dahran N, Szewczyk-Bieda M, Wei C, Vinnicombe S, Nabi G. Normalized periprostatic fat MRI measurements can predict prostate cancer aggressiveness in men undergoing radical prostatectomy for clinically localised disease. Sci Rep. 2017;7(1):4630. https:\/\/doi.org\/10.1038\/s41598-017-04951-8.","journal-title":"Sci Rep"},{"issue":"3","key":"1884_CR6","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1158\/1541-7786.Mcr-18-0748","volume":"17","author":"V Laurent","year":"2019","unstructured":"Laurent V, Toulet A, Attan\u00e9 C, et al. Periprostatic adipose tissue favors prostate cancer cell invasion in an Obesity-Dependent manner: role of oxidative stress. Mol Cancer Res. 2019;17(3):821\u201335. https:\/\/doi.org\/10.1158\/1541-7786.Mcr-18-0748.","journal-title":"Mol Cancer Res"},{"issue":"7","key":"1884_CR7","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1111\/j.1464-410X.2012.10957.x","volume":"110","author":"B Bhindi","year":"2012","unstructured":"Bhindi B, Trottier G, Elharram M, et al. Measurement of peri-prostatic fat thickness using transrectal ultrasonography (TRUS): a new risk factor for prostate cancer. BJU Int. 2012;110(7):980\u20136. https:\/\/doi.org\/10.1111\/j.1464-410X.2012.10957.x.","journal-title":"BJU Int"},{"issue":"14","key":"1884_CR8","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1002\/pros.24054","volume":"80","author":"C Di Bella","year":"2020","unstructured":"Di Bella C, Howard L, Oyekunle T, et al. Abdominal and pelvic adipose tissue distribution and risk of prostate cancer recurrence after radiation therapy. Prostate. 2020;80(14):1244\u201352. https:\/\/doi.org\/10.1002\/pros.24054.","journal-title":"Prostate"},{"issue":"1","key":"1884_CR9","doi-asserted-by":"publisher","first-page":"2201964","DOI":"10.1080\/21623945.2023.2201964","volume":"12","author":"T Xiong","year":"2023","unstructured":"Xiong T, Cao F, Zhu G, et al. MRI-measured periprostatic adipose tissue volume as a prognostic predictor in prostate cancer patients undergoing laparoscopic radical prostatectomy. Adipocyte. 2023;12(1):2201964. https:\/\/doi.org\/10.1080\/21623945.2023.2201964.","journal-title":"Adipocyte"},{"issue":"1","key":"1884_CR10","doi-asserted-by":"publisher","first-page":"W43","DOI":"10.2214\/ajr.14.12689","volume":"204","author":"S Woo","year":"2015","unstructured":"Woo S, Cho J, Kim S, Kim S. Periprostatic fat thickness on MRI: correlation with Gleason score in prostate cancer. AJR Am J Roentgenol. 2015;204(1):W43\u20137. https:\/\/doi.org\/10.2214\/ajr.14.12689.","journal-title":"AJR Am J Roentgenol"},{"key":"1884_CR11","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.urology.2016.07.042","volume":"98","author":"W Tan","year":"2016","unstructured":"Tan W, Lin C, Chen M, Deane L, Periprostatic Fat. A risk factor for prostate cancer?? Urology. 2016;98:107\u201312. https:\/\/doi.org\/10.1016\/j.urology.2016.07.042.","journal-title":"Urology"},{"issue":"2","key":"1884_CR12","doi-asserted-by":"publisher","first-page":"37.e1-e9","DOI":"10.1016\/j.urolonc.2019.10.008","volume":"38","author":"T Zhai","year":"2020","unstructured":"Zhai T, Jin L, Hu L, et al. Impact of peri-prostatic fat measurements using MRI on the prediction of prostate cancer with transrectal ultrasound-guided biopsy. Urol Oncol. 2020;38(2):37.e1-e9. https:\/\/doi.org\/10.1016\/j.urolonc.2019.10.008.","journal-title":"Urol Oncol"},{"issue":"2","key":"1884_CR13","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s40618-020-01294-6","volume":"44","author":"T Zhai","year":"2021","unstructured":"Zhai T, Hu L, Ma W, et al. Peri-prostatic adipose tissue measurements using MRI predict prostate cancer aggressiveness in men undergoing radical prostatectomy. J Endocrinol Invest. 2021;44(2):287\u201396. https:\/\/doi.org\/10.1007\/s40618-020-01294-6.","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"1884_CR14","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1097\/ju.0000000000001321","volume":"205","author":"J Gregg","year":"2021","unstructured":"Gregg J, Surasi D, Childs A, et al. The association of periprostatic fat and grade group progression in men with localized prostate cancer on active surveillance. J Urol. 2021;205(1):122\u20138. https:\/\/doi.org\/10.1097\/ju.0000000000001321.","journal-title":"J Urol"},{"issue":"5","key":"1884_CR15","doi-asserted-by":"publisher","first-page":"e1036","DOI":"10.1016\/j.clgc.2019.06.001","volume":"17","author":"H Huang","year":"2019","unstructured":"Huang H, Chen S, Li W, Bai P, Wu X, Xing J. Periprostatic fat thickness on MRI is an independent predictor of time to Castration-resistant prostate cancer in Chinese patients with newly diagnosed prostate cancer treated with androgen deprivation therapy. Clin Genitourin Cancer. 2019;17(5):e1036\u201347. https:\/\/doi.org\/10.1016\/j.clgc.2019.06.001.","journal-title":"Clin Genitourin Cancer"},{"issue":"6","key":"1884_CR16","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.euf.2017.01.019","volume":"4","author":"M Salji","year":"2018","unstructured":"Salji M, Hendry J, Patel A, Ahmad I, Nixon C, Leung H. Peri-prostatic fat volume measurement as a predictive tool for castration resistance in advanced prostate cancer. Eur Urol Focus. 2018;4(6):858\u201366. https:\/\/doi.org\/10.1016\/j.euf.2017.01.019.","journal-title":"Eur Urol Focus"},{"key":"1884_CR17","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/s0022-5347(17)37393-7","volume":"147","author":"M Benson","year":"1992","unstructured":"Benson M, Whang I, Pantuck A, et al. Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer. J Urol. 1992;147:815\u20136. https:\/\/doi.org\/10.1016\/s0022-5347(17)37393-7.","journal-title":"J Urol"},{"issue":"3","key":"1884_CR18","doi-asserted-by":"publisher","first-page":"300","DOI":"10.4103\/aja.aja_61_20","volume":"23","author":"Z Song","year":"2021","unstructured":"Song Z, Qian J, Yang Y, et al. PSA density in the diagnosis of prostate cancer in the Chinese population: results from the Chinese prostate cancer consortium. Asian J Androl. 2021;23(3):300\u20135. https:\/\/doi.org\/10.4103\/aja.aja_61_20.","journal-title":"Asian J Androl"},{"key":"1884_CR19","doi-asserted-by":"publisher","unstructured":"Borkowetz A, Lohse-Fischer A, Scholze J, et al. Evaluation of MicroRNAs as non-invasive diagnostic markers in urinary cells from patients with suspected prostate cancer. Diagnostics (Basel). 2020;10(8). https:\/\/doi.org\/10.3390\/diagnostics10080578.","DOI":"10.3390\/diagnostics10080578"},{"issue":"6","key":"1884_CR20","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s00345-009-0497-7","volume":"28","author":"J van Roermund","year":"2010","unstructured":"van Roermund J, Bol G, Witjes J, Ruud Bosch J, Kiemeney L, van Vulpen M. Periprostatic fat measured on computed tomography as a marker for prostate cancer aggressiveness. World J Urol. 2010;28(6):699\u2013704. https:\/\/doi.org\/10.1007\/s00345-009-0497-7.","journal-title":"World J Urol"},{"issue":"20","key":"1884_CR21","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1056\/NEJMoa0801891","volume":"359","author":"T Pischon","year":"2008","unstructured":"Pischon T, Boeing H, Hoffmann K, et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med. 2008;359(20):2105\u201320. https:\/\/doi.org\/10.1056\/NEJMoa0801891.","journal-title":"N Engl J Med"},{"issue":"11","key":"1884_CR22","doi-asserted-by":"publisher","first-page":"3252","DOI":"10.1158\/1055-9965.Epi-08-0609","volume":"17","author":"T Pischon","year":"2008","unstructured":"Pischon T, Boeing H, Weikert S, et al. Body size and risk of prostate cancer in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev. 2008;17(11):3252\u201361. https:\/\/doi.org\/10.1158\/1055-9965.Epi-08-0609.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"1884_CR23","first-page":"1793","volume":"11","author":"Q Zhang","year":"2014","unstructured":"Zhang Q, Sun L, Qi J, Yang Z, Huang T, Huo R. Periprostatic adiposity measured on magnetic resonance imaging correlates with prostate cancer aggressiveness. Urol J. 2014;11(4):1793\u20139.","journal-title":"Urol J"},{"issue":"11","key":"1884_CR24","doi-asserted-by":"publisher","first-page":"e112355","DOI":"10.1371\/journal.pone.0112355","volume":"9","author":"C Hung","year":"2014","unstructured":"Hung C, Lee J, Yang C, et al. Measurement of visceral fat: should we include retroperitoneal fat? PLoS ONE. 2014;9(11):e112355. https:\/\/doi.org\/10.1371\/journal.pone.0112355.","journal-title":"PLoS ONE"},{"key":"1884_CR25","first-page":"0","volume":"0","author":"ZD Nassar","year":"2018","unstructured":"Nassar ZD, Aref AT, Miladinovic D, et al. Peri-prostatic adipose tissue: the metabolic microenvironment of prostate cancer[. J] BJU Int. 2018;0:0.","journal-title":"J] BJU Int"},{"key":"1884_CR26","doi-asserted-by":"publisher","first-page":"0","DOI":"10.1016\/j.ajpath.2022.03.008","volume":"192","author":"M Roumigui\u00e9","year":"2022","unstructured":"Roumigui\u00e9 M, Est\u00e8ve D, Manceau C, et al. Periprostatic adipose tissue displays a chronic hypoxic state that limits its Expandability.[J]. Am J Pathol. 2022;192:0.","journal-title":"Am J Pathol"},{"key":"1884_CR27","doi-asserted-by":"publisher","first-page":"0","DOI":"10.1186\/s12964-023-01294-y","volume":"21","author":"A Alvarez-Artime","year":"2023","unstructured":"Alvarez-Artime A, Garcia-Soler B, Gonzalez-Menendez P, et al. Castration promotes the Browning of the prostate tumor microenvironment.[J]. Cell Commun Signal. 2023;21:0.","journal-title":"Cell Commun Signal"},{"issue":"1","key":"1884_CR28","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1080\/21623945.2022.2148885","volume":"11","author":"T Xiong","year":"2022","unstructured":"Xiong T, Cao F, Zhu G, et al. MRI-measured adipose features as predictive factors for detection of prostate cancer in males undergoing systematic prostate biopsy: a retrospective study based on a Chinese population. Adipocyte. 2022;11(1):653\u201364. https:\/\/doi.org\/10.1080\/21623945.2022.2148885.","journal-title":"Adipocyte"},{"key":"1884_CR29","doi-asserted-by":"publisher","unstructured":"Lee J, Jeon Y, Kim K, Yang H, Lee C, Lee S. Prognostic value of CT-attenuation and F-fluorodeoxyglucose uptake of periprostatic adipose tissue in patients with prostate cancer. J Pers Med. 2020;10(4). https:\/\/doi.org\/10.3390\/jpm10040185.","DOI":"10.3390\/jpm10040185"},{"issue":"4","key":"1884_CR30","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1097\/01.ju.0000055903.18400.25","volume":"169","author":"K Saglam","year":"2003","unstructured":"Saglam K, Aydur E, Yilmaz M, G\u00f6kta\u015f S. Leptin influences cellular differentiation and progression in prostate cancer. J Urol. 2003;169(4):1308\u201311. https:\/\/doi.org\/10.1097\/01.ju.0000055903.18400.25.","journal-title":"J Urol"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-025-01884-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-025-01884-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-025-01884-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T16:14:07Z","timestamp":1757348047000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/s12894-025-01884-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,11]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1884"],"URL":"https:\/\/doi.org\/10.1186\/s12894-025-01884-7","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,11]]},"assertion":[{"value":"12 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Ethics Committee of The Second Affiliated of Chongqing Medical University approved this retrospective study and granted an exemption from the requirement for informed consent (Decision No. 289, 2019).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"199"}}